Clinical Trials Sponsored by Immutep S.A.S.

Total 372 results

Immutep S.A.S.

Recruiting

Study in Metastatic Breast Cancer Patients Receiving Eftilagimod Alpha or Placebo in Combination With Paclitaxel Chemotherapy (AIPAC-003)

Breast Carcinoma

Spain, United States, Belgium
Immutep S.A.S.

Completed

IMP321 (Eftilagimod Alpha) as Adjunctive to a Standard Chemotherapy Paclitaxel Metastatic Breast Carcinoma

Adenocarcinoma Breast Stage IV

Netherlands, United Kingdom, France, Belgium, Germany, Hungary, Poland
Immutep S.A.S.

Withdrawn

A Study in Hormone Receptor-positive Metastatic Breast Carcinoma Patients to Test a New Schedule of Efti (IMP321, Eftilagimod Alpha) as Adjunctive to a Weekly Treatment Regimen of Paclitaxel (AIPAC-002)

Metastatic Breast Cancer
Immutep S.A.S.
Umanis

Completed

IMP321 Plus First-line Paclitaxel in Metastatic Breast Carcinoma

Metastatic Breast Cancer

France
Immutep S.A.S.
Umanis

Completed

IMP321 Phase 1 Trial in Metastatic Renal Cell Carcinoma (MRCC)

Stage IV Renal Cell Carcinoma

France
Immutep S.A.S.
SGS Aster-Cephac (CRO)

Completed

Phase I Study of IMP321 Given Alone or as an Adjuvant to a Reference Flu Antigen

Healthy

France
Immutep S.A.S.
Merck Sharp & Dohme LLC

Active, not recruiting

Combination Study With Soluble LAG-3 Fusion Protein Eftilagimod Alpha (IMP321) and Pembrolizumab in Patients With Previously Untreated Unresectable or Metastatic NSCLC, or Recurrent PD-X Refractory NSCLC or With Recurrent or Metastatic HNSCC (TACTI-002)

NSCLC | HNSCC

Spain, United States, United Kingdom, Australia, Ukraine
Immutep S.A.S.
Merck Sharp & Dohme LLC

Recruiting

Combination Study With Eftilagimod Alpha (a Soluble LAG-3 Fusion Protein) and Pembrolizumab in Patients With Recurrent or Metastatic HNSCC (TACTI-003)

HNSCC

United States, Belgium, Spain, United Kingdom, Denmark, Germany, Australia, Romania, Ukraine
Centre Hospitalier Universitaire Vaudois
Immutep S.A.S.

Terminated

Immunotherapy of HLA-A2 Positive Stage II-IV Melanoma Patients (LAG-3/IMP321)

Melanoma

Switzerland
Immutep S.A.S.
SGS Aster-Cephac (CRO)

Completed

A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321

Healthy

France
Maria Sklodowska-Curie National Research Institute...
Immutep S.A.S.

Recruiting

Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial (EFTISARC-NEO)

Immunotherapy | Sarcoma,Soft Tissue | Radiation Therapy | Neoadjuvant

Poland
Cliniques universitaires Saint-Luc- Université...
Immutep S.A.S.

Terminated

Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides

Melanoma

Belgium
Laboratoires Coloplast S.A.S

Completed

Observational Study of the Quality of Life of New Ostomates Using SenSura Mio Appliances With BodyFit Technology (QoLMio)

Ostomy

France
Dedienne Sante S.A.S.

Completed

Retrospective Observational Cohort Study of SYMBOL CUP DM 1 (SYMCOR-1)

Primary Total Hip Arthroplasty

France
Janssen Cilag S.A.S.

Completed

A Study to Characterize Profile of Participant With Psoriatic Arthritis Depending on Whether Their Disease is Managed by a Dermatologist or by a Rheumatologist, and Starting Ustekinumab (PROUST)

Psoriatic Arthritis

France
Dedienne Sante S.A.S.

Completed

Retrospective Observational Cohort Study of SYMBOL CUP DM 2 (SYMCOR-2)

Primary Total Hip Arthroplasty | Revision Total Hip Arthroplasty

France
Janssen Cilag S.A.S.

Terminated

Effects of Early Correction of Anemia in Patients With Chronic Renal Insufficiency

Anemia | Renal Failure, Chronic Renal Failure
Janssen Cilag S.A.S.

Terminated

Evaluation of the Efficacy and Safety of Fentanyl Delivered by Adhesive Skin Patch in Out-Patients With Chronic Cancer Pain

Pain
Janssen Cilag S.A.S.

Recruiting

Benefits of Individual Physical Activity Intervention on Health-related Quality of Life in Participants With Chronic Lymphocytic Leukemia (QOLIBRI)

Leukemia, Lymphocytic, Chronic, B-Cell

France
Laboratoires Coloplast S.A.S

Recruiting

Study of the Criteria for Choosing Speedicath Catheters During the Initiation of Self-catheterization (Eva)

Urinary Retention

France
Janssen Cilag S.A.S.

Completed

Real-world Effectiveness of Ustekinumab in Participants Suffering From Inflammatory Bowel Disease (Crohn's Disease or Ulcerative Colitis) With Extra-intestinal Manifestations or Immune-mediated Inflammatory Diseases (TENOR)

Crohn Disease | Colitis, Ulcerative

France
Janssen Cilag S.A.S.

Completed

Influence of Rabeprazole on the Magnitude of the Antiplatelet Action of Clopidogrel (CLARA)

Healthy
Janssen Cilag S.A.S.

Completed

Effect of Early High-dose Epoetin Alfa During Cardiac Arrest (Pilot Study)

Cardiac Arrest | Resuscitation | Cardiopulmonary
Kinnov Therapeutics

Not yet recruiting

A Study to Assess the Pharmacokinetic Profile of Prazosin and Cyproheptadine

Alcohol Use Disorder
Ayudas Diagnosticas Sura S.A.S

Not yet recruiting

Ivermectina Colombia (IVERCOL) (IVERCOL)

COVID-19 Pneumonia
Dedienne Sante S.A.S.
EVAMED

Recruiting

Safety and Performance Assessment of the SYMBOL Range of Medical Devices in Patients Underlying Total Hip Arthroplasty

Post-traumatic Osteoarthritis | Femoral Neck Fractures | Hip Arthritis | Avascular Necrosis of the Femoral Head | Failure of Prosthetic Joint Implant | Degenerative Hip Joint Disease

France
Instituto Palacios
Nexentia S.A.S.

Completed

Clinical Trial to Evaluate the Tolerability and Efficacy of Microencapsulated Calcium Carbonate (CALCIMIP)

Hypocalcemia; Dietary

Spain
Maco Productions S.A.S.
SynteractHCR

Completed

A Prospective Non-interventional Study to Evaluate the Safety of Methylene Blue Plasma

Adverse Effects in the Therapeutic Use of Plasma Substitutes

United Kingdom, Belgium, Greece, Spain
Grupo Rescue S.A.S República Dominicana

Completed

SARS-CoV-2 Pre-exposure Prophylaxis With Ivermectin Retrospective Cohort Study

Covid19

Dominican Republic
University Hospital, Montpellier
Medtech S.A.S

Completed

Robotic-assisted Pedicule Screw Placement (ARASS)

Lumbar Degenerative Spinal Disease

France
Kinnov Therapeutics
ECSOR

Completed

Clinical Outcome of a Patented Pharmaceutical Composition (KT-110) to Treat Alcohol Use Disorder While Avoiding Major Side Effects (COCKTAIL)

Alcohol Use Disorder

France
Genfit
Naturalpha; SGS Aster S.A.S.

Completed

Comparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505

Cardiovascular Diseases | Metabolic Diseases | Diabetes Mellitus, Type 2 | Type 2 Diabetes | Dyslipidemia | Obese

France
Dermofarm, S.A.U

Completed

Efficacy and Safety of a Hyaluronic Acid-Based Vaginal Moisturizer Medical Device to Ease Symptoms of Vaginal Dryness (HYALU-LAUDE)

Vaginal Disease

Spain
Greenpharma S.A.S.
Complife Italia S.r.l

Completed

A Controlled Study to Evaluate the Efficacy and the Tolerability of a Cosmetic Active Ingredient Intended for Subjects With Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Italy
Astellas Pharma S.A.S.

Completed

A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®) (OPALE)

Renal Transplantation

France
Astellas Pharma S.A.S.

Completed

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients (DAFNE)

Clostridium Difficile Infection

France
University Hospital, Bordeaux
IPSEN PHARMA S.A.S

Completed

Restless Legs Syndrome Treatment With Botulinum Toxin (SOXIS)

Restless Legs Syndrome

France
Tigenix S.A.U.

Completed

Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.

Crohn's Disease | Anal Fistula

Spain
Tigenix S.A.U.

Completed

Intralymphatic eASC Administration in Healthy Volunteers

Localized Adverse Reaction to Administration of Drug

Spain
Tigenix S.A.U.

Completed

Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers (CELLULA)

Sepsis

Netherlands
Tigenix S.A.U.

Completed

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) (ADMIRE-CD-II)

Crohn's Disease

United States, Spain, United Kingdom, Italy, Germany, Canada, Belgium, Denmark, Poland, Czechia, France, Hungary, Israel, Puerto Rico, Sweden
Fagron Iberica S.A.U.

Completed

Retrospective Study of ImmunoFormulation for COVID-19

Covid19

Spain
Tigenix S.A.U.

Completed

Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa (TCEB)

EPIDERMOLYSIS BULLOSA

Spain
Tigenix S.A.U.

Completed

Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled Trial (LTE)

Complex Perianal Fistula

Spain
Tigenix S.A.U.

Completed

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

Rheumatoid Arthritis Aggravated

Spain
Eske Corporation S.A.C

Terminated

Randomized Clinical Trial Evaluating the Use of the Laser-Assisted Immunotherapy (LIT/inCVAX) in Advanced Breast Cancer

Breast Cancer Stage IV | Breast Cancer Stage IIIA | Breast Cancer, Stage IIIB

Peru
Astellas Pharma S.A.S.

Completed

A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year (COBALT)

Liver Transplantation

France
Astellas Pharma S.A.S.

Completed

Use of Micafungin (Mycamine®) as Antifungal Prophylaxis in Haematology and Onco-haematology (OLYMPE)

Antifungal Prophylaxis | Haemopathy

France
Tigenix S.A.U.

Completed

Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease (ADMIRE-CD)

Crohn's Disease

Spain, Belgium, Netherlands, France, Israel, Italy, Austria, Germany
Tigenix S.A.U.

Completed

Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease (FATT1)

Anal Fistula

Spain, Germany, United Kingdom

3

Subscribe